La investigació es realitza parcialment en les instal·lacions del Laboratori de Recerca Translacional de l’Institut Català d’Oncologia (ICO) -Bellvitge Institut de Recerca Biomèdica (IDIBELL) en virtut d’un acord marc entre ambdues entitats.
La investigació es realitza parcialment en les instal·lacions del Laboratori de Recerca Translacional de l’Institut Català d’Oncologia (ICO) -Bellvitge Institut de Recerca Biomèdica (IDIBELL) en virtut d’un acord marc entre ambdues entitats.
SANCHO PARDO, GEMMA FGS
gsancho@santpau.cat
Balart Serra, Josep FGS
Farre Bernado, Nuria FGS
Isern Verdum, Josep FGS
Julia Sanahuja, Joan Carles FGS
Majercakova , Katarina FGS
Mera Errasti, Maria Arantzazu FGS
Montezuma Niño, Laura Constanza FGS
Pedro Olive, Agusti FGS
Pla Sanchez, Monica IR
Rojas Cordero, Jady Vivian FGS
Soto Cambres, Ana Maria FGS
Vila Capel, Antoni FGS
Borras J.M., Font R., Sola J., Macia M., Tuset V., Arenas M., Eraso A., Verges R., Farre N., Pedro A., Molla M., Algara M., Sole J.M., Mira M., Espinas J.A. (2020) Impact of non-adherence to radiotherapy on 1-year survival in cancer patients in Catalonia, Spain. RADIOTHER ONCOL, 151 (), 200-205.
IF: 6,280
Carrato C., Alameda F., Esteve-Codina A., Pineda E., Arpi O., Martinez-Garcia M., Mallo M., Gut M., Lopez-Martos R., Barco S.D., Ribalta T., Capellades J., Puig J., Gallego O., Mesia C., Munoz-Marmol A.Ma., Archilla I., Arumi M., Blanc J.M., Bellosillo B., Menendez S., Esteve A., Bague S., Hernandez A., Craven-Bartle J., Fuentes R., Vidal N., Aldecoa I., de la Iglesia N., Balana C. (2020) Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by ihc and have an immune-phenotype indicating a potential benefit from immunotherapy. CLIN CANCER RES, 26 (24), 6600-6609.
IF: 12,531
Lopez-Campos F., Linares-Espinos E., Maldonado Pijoan X., Sancho Pardo G., Morgan T.M., Martinez-Ballesteros C., Martinez-Salamanca J., Counago F. (2020) Genetic testing for the clinician in prostate cancer. EXPERT REV MOL DIAGN, 20 (9), 933-946.
IF: 5,225
Marta G.N., Coles C., Kaidar-Person O., Meattini I., Hijal T., Zissiadis Y., Pignol J.-P., Ramiah D., Ho A.Y., Cheng S.H.-C., Sancho G., Offersen B.V., Poortmans P. (2020) The use of moderately hypofractionated post-operative radiation therapy for breast cancer in clinical practice: A critical review. CRIT REV ONCOL HEMAT, 156 (), -.
IF: 6,312
Martin-Broto J; Hindi, N; Lopez-Pousa A; Peinado-Serrano J; Alvarez R; Alvarez-Gonzalez A; Italiano A; Sargos P; Cruz-Jurado J; Isern-Verdum J, et al. Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue SarcomasA Nonrandomized Phase 1/2 Clinical Trial. JAMA ONCOL. 2020;6(4):535-541. doi:10.1001/jamaoncol.2019.6584.
IF: 31,777